Saturday 28th March 2020 • Promotional Content


potential harmful impact all the more devastating. During pregnancy, the targets for


glucose levels are tighter, making the management of T1D more challenging than ever. High HbA1c is the result of frequent


hyperglycaemia, when the average glucose levels run high. It’s key to reduce time spent in hyperglycaemia in order to achieve successful preg- nancy outcomes for mother and child. Tere are substantial increased


risks for women whose glucose levels are too high in the later stages of pregnancy, too, according to the National Pregnancy in Diabetes (NPID) 2019 audit. “For women with third trimester


HbA1c levels at or above 48 mmol/mol, rates of preterm births, LGA [large for gestational age] and neonatal care admissions were significantly higher than for women with lower glucose levels,” the audit says. Achieving and maintaining glucose


levels that avoid hyper- and hypo- glycaemia requires regular glucose monitoring. NICE currently recom- mends that pregnant women with T1D test their glucose levels at least seven times a day. However, these recommendations


must be considered alongside the fact that the NPID reports: “Tere’s a higher level of stillbirths and neonatal death, along with congenital abnor- malities, in women with pre-existing diabetes compared to the general population. Tis hasn’t changed over five years of NPID measurement.” Te NPID reported neonatal death


rates were 10.4 per 1,000 live births in 2018, across all diabetes types


1NICE RECOMMENDATION NG3. 2 3NHS LONG TERM PLAN, P. 65. 4


NG3. 5 NG3. 7


T1D requires constant monitoring and treatment, never more so than during pregnancy when a woman’s body is ever changing, and the potential harmful impact all the more devastating


— much higher than the previous year’s neonatal death rate for the UK population of 2.8 deaths per 1,000 live births. Tese devastating statistics have the


informed new recommenda-


tion from NICE, stating all pregnant women with type 1 diabetes will be offered CGM because it’s clinically proven to


improve neonatal this and


maternal outcomes. Dexcom applauds and welcomes new funding


and hopes to


continue to see the real-life impact of CGM on families like Olivia’s.


THE FUTURE FOR PREGNANCY WITH DIABETES From this spring, women with T1D who fall pregnant will have improved access to NHS-funded CGM as Olivia did.3 this


Dexcom applauds and welcomes new funding


NATIONAL PREGNANCY IN DIABETES AUDIT 2019 (NPID), P. 19-20. NPID, P. 52. 6


NPID, P. 13. and hopes to


continue to see the real-life impact of CGM on families like Olivia’s.


Innovative healthcare & alternative remedies Healthcare Innovations 15


WHAT IS TYPE 1 DIABETES?


T1D is an autoimmune condition that can occur at any age. It’s distinct from type 2 diabetes, which is the most common type of diabetes. Around 400,000 people in the UK live with T1D. T1D occurs when the body attacks the insulin-producing beta cells in the pancreas, making it impossible for the body to produce its own insulin, and therefore unable to regulate its own glucose levels. The treatment is to take insulin externally either via insulin injections, pens or pump. A person with T1D must inject insulin multiple times a day for the rest of their lives. Too little insulin causes glucose levels to rise too high (hyperglycaemia), putting a person with T1D at short-term risk of life-threatening diabetic ketoacidosis and long-term risk of damage to their eyes, kidneys and/or feet. On the other hand, too much insulin causes glucose levels to fall too low (hypoglycaemia), which carries with it the short-term risk of unconsciousness, seizures and even death. This tightrope walk of balancing insulin is only possible by knowing what your glucose level is. A person with T1D must constantly monitor their glucose levels in order to limit instances of hyper- and hypoglycaemia as much as possible, therefore minimising the associated risks. The more glucose information available, the more informed treatment decisions with insulin are.


Speak to your healthcare team about Dexcom or find out more at dexcom.com/en-gb Call Customer Service on 0800 031 5761 Follow us on Facebook – Search Dexcom UK and Ireland Follow us on Instagram - @dexcomukandire


Sources: 1


National Pregnancy in Diabetes Audit 2019 (NPID) files.digital.nhs.uk/CF/4791D9/National%20Pregnancy%20in%20


NICE Recommendation NG3 www.nice.org.uk/guidance/ng3/chapter/1-Recommendations#antenatal-care-for-wom- en-with-diabetes-2


Diabetes%20Audit%20Report%202018.pdf 2


3NHS Long Term Plan www.longtermplan.nhs.uk/wp-content/uploads/2019/08/nhs-long-term-plan-version-1.2.pdf


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36